A prospective multicenter study of sirolimus for complicated vascular anomalies
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (5) , 1673-1681.e3
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81400862, 81401606)
- Sichuan University (2019HXFH056, 2020HXFH048)
- Science Foundation for Excellent Youth Scholars of Sichuan University (2015SU04A15)
- Key Science and Technology Program of Shaanxi Province (2019YFS0322)
This publication has 31 references indexed in Scilit:
- Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular AnomaliesPediatrics, 2015
- Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CAThe Journal of Pediatrics, 2015
- Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisoloneDermatologic Therapy, 2015
- Vascular Anomalies of the Hand and WristJournal of the American Academy of Orthopaedic Surgeons, 2014
- Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic AnomalyThe Journal of Pediatrics, 2014
- Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach–Merritt phenomenonPediatric Blood & Cancer, 2012
- Sildenafil for Severe Lymphatic MalformationsNew England Journal of Medicine, 2012
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- Treatment of childhood kaposiform hemangioendothelioma with sirolimusPediatric Blood & Cancer, 2010
- Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous NephropathyJournal of the American Society of Nephrology, 2005